Associate Professor Samantha Ginn is a senior researcher in the Gene Therapy Research Unit at the Children’s Medical Research Institute, Sydney. Her research focuses on the development and translation of genome editing technologies for inherited metabolic diseases, with expertise in viral vector engineering, targeted genome integration and preclinical humanised models. She is President of the Australasian Gene and Cell Therapy Society (AGCTS) and is committed to advancing the clinical translation of genome editing therapies.